Geriatric Medicine Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
General Medicine Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
J Hum Genet. 2018 Jun;63(6):731-737. doi: 10.1038/s10038-018-0435-x. Epub 2018 Mar 19.
The CYP17A1 gene, which encodes17α-hydroxylase and 17,20-lyase, has been identified as a common hypertension susceptibility locus in a European population. However, the association between CYP17A1 polymorphisms and hypertension is unclear in the Chinese population as well as in the role of serum 25(OH) D levels. Six single nucleotide polymorphisms (SNPs) in CYP17A1 were genotyped in two stages in a Han Chinese population, and the serum 25(OH) D levels were measured. Analysis in stage 1 showed that the rs1004467 minor G-allele and rs11191548 minor C-allele in CYP17A1 were significantly associated with a decreased risk of hypertension and higher serum 25(OH) D levels (all P < 0.05). The larger sample in stage 2 also showed that a mutation in rs11191548 was significantly associated with a decreased risk of hypertension (adjusted OR = 0.707, 95% CI: 0.553-0.904, P = 0.006). The rs11191548 minor C-allele was associated with higher serum 25(OH) D levels in hypertensive subjects (βadj ± SEM = 0.094 ± 0.949, P = 0.003) and controls (βadj ± SEM = 0.128 ± 1.025, P < 0.001). In conclusion, the rs11191548 CYP17A1 gene mutation was associated with hypertension and the serum 25(OH) D levels in Han Chinese.
CYP17A1 基因编码 17α-羟化酶和 17,20-裂合酶,已被确定为欧洲人群中常见的高血压易感基因座。然而,CYP17A1 多态性与高血压的关联在中国人群以及血清 25(OH)D 水平中的作用尚不清楚。在汉族人群中进行了两个阶段的 CYP17A1 六个单核苷酸多态性 (SNP) 基因分型,并测量了血清 25(OH)D 水平。第一阶段的分析表明,CYP17A1 中的 rs1004467 次要 G-等位基因和 rs11191548 次要 C-等位基因与高血压风险降低和血清 25(OH)D 水平升高显著相关(均 P<0.05)。第二阶段的更大样本也表明,rs11191548 突变与高血压风险降低显著相关(调整后的 OR=0.707,95%CI:0.553-0.904,P=0.006)。rs11191548 次要 C-等位基因与高血压患者(βadj±SEM=0.094±0.949,P=0.003)和对照组(βadj±SEM=0.128±1.025,P<0.001)的血清 25(OH)D 水平升高相关。总之,CYP17A1 基因 rs11191548 突变与汉族人群中的高血压和血清 25(OH)D 水平相关。